TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
5月 08, 2026
2 min read
9

The OMX Copenhagen 20 index concluded Friday's trading session with a notable decline, closing down 0.95%. The downward movement was primarily influenced by poor performance in key growth sectors, signaling a cautious sentiment among investors.
The main drivers behind the index's fall were significant losses within the Software & Computer Services, Healthcare, and Technology sectors. According to closing data, falling stocks on the Copenhagen Stock Exchange outnumbered advancing ones by 74 to 38, with 21 stocks remaining unchanged, underscoring the broad-based nature of the sell-off.
Genmab (CSE:GMAB) was the session's worst performer, with its shares plummeting by 6.65%. Other significant losers included Rockwool AS B (CSE:ROCKb) and Demant A/S (CSE:DEMANT), which fell 2.30% and 2.10% respectively. In contrast, Novozymes AS (CSE:NSISb) emerged as a top gainer, rising 1.47%, followed by positive performances from AP Moeller - Maersk and Jyske Bank.
The session's results highlight investor retreat from technology and healthcare stocks. Market participants will likely watch for further economic indicators to gauge future market direction, while commodity markets saw oil and gold prices advance.
Q: Which Danish index was primarily affected?
A: The OMX Copenhagen 20 index declined by 0.95%.
Q: Which company experienced the largest drop?
A: Genmab was the worst performer, with its stock price falling 6.65%.
Q: Were there any significant gaining stocks?
A: Yes, Novozymes AS was the best performer, with a gain of 1.47%.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles